 | Up a level |
Tschudin-Sutter, S., Kuijper, E. J., Durovic, A., Vehreschild, M. J. G. T., Barbut, F., Eckert, C., Fitzpatrick, F., Hell, M., Noren, T., O'Driscoll, J., Coia, J., Gastmeier, P., von Mueller, L., Wilcox, M. H. and Widmer, A. F. (2018). Guidance document for prevention of Clostridium difficile infection in acute healthcare settings. Clin. Microbiol. Infect., 24 (10). S. 1051 - 1055. OXFORD: ELSEVIER SCI LTD. ISSN 1469-0691
Wilcox, M. H., Gerding, D. N., Poxton, I. R., Kelly, C., Nathan, R., Birch, T., Cornely, O. A., Rahav, G., Bouza, E., Lee, C., Jenkin, G., Jensen, W., Kim, Y. -S., Yoshida, J., Gabryelski, L., Pedley, A., Eves, K., Tipping, R., Guris, D., Kartsonis, N. and Dorr, M. -B. (2017). Bezlotoxumab for Prevention of Recurrent Clostridium difficile Infection. N. Engl. J. Med., 376 (4). S. 305 - 318. WALTHAM: MASSACHUSETTS MEDICAL SOC. ISSN 1533-4406